Feed QNCX
QN
Quince Therapeutics, Inc.
QNCX · NASDAQ
$34.04 +1.70% (+$0.57)
1M +80.87%
Market Cap $9.5M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$38.53
13.2% upside
Preț actual
$34.04
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile QNCX sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.60x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 227.61%
ROA 124.09%
Debt
76 /100
Low Int. coverage 1.87x
Debt/Equity 0.03x
Current ratio 2.92x
Stability
31 /100
Unstable Profitable years 0
Beta 1.40x
EPS volatility 52.41%
Întreabă StockBot despre QNCX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dirk Thye
Employees
38
Headquarters
South San Francisco
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report